Accreditation & Objectives

National Conference & Exhibition: September 27 – October 1, 2024*

• Live in-person content is available 9/27/2024-10/1/2024.
• Internet Live content is available 9/27/2024-10/1/2024.
• Internet Enduring content is available 10/2/2024-1/31/2025.
• Credit must be claimed between 10/02/2024-1/31/2025.

Purpose of the National Conference

The National Conference & Exhibition is dedicated to keeping pediatric providers abreast of the latest best practices in pediatrics. Whether attendees are looking to obtain continuing medical education (CME) credits or dedicated to lifelong learning, this conference provides a large selection of pediatric educational opportunities. The National Conference & Exhibition strives to meet participants’ identified educational needs and support their lifelong learning with a goal of improving care for children and families. The AAP is committed to excellence and innovation in education. The AAP National Conference is the forum at which pediatric professionals meet and interact for updates, review of pediatric practice, research, and advocacy. The National Conference provides a place for the AAP governance/administration/organization to interact with its general membership.

Goals and Objectives

The National Conference & Exhibition strives to meet participants’ identified educational needs and support their lifelong learning with a goal of improving care for children and families. The AAP is committed to excellence and innovation in education. The AAP National Conference is the forum at which pediatric professionals meet and interact for updates, review of pediatric practice, research, and advocacy. The National Conference provides a place for the AAP governance/administration/organization to interact with its general membership.

The content of this CME activity does not necessarily reflect the views or policies of the American Academy of Pediatrics.

Instructional Objectives

The instruction (learning experience) in this activity will:

  • Provide the most current information related to illness and preventive healthcare of prenatal, neonatal, infants, children, adolescents, and young adults.
  • Create a forum for discussion of current issues and problems in pediatric healthcare.
  • Instruct attendees on procedures related to patient health management.
  • Inform, enable and update on practice management and policy.
  • Support and train attendees in advocacy of issues related to child health.
  • Highlight the importance of physician self-care and wellness and their impact on patient care

Learner Objectives

As a result of attending this activity, learners will be able to:

  • Practice evidence-based, informed pediatric medicine.
  • Apply current techniques and procedures.
  • Advocate effectively for issues related to children’s health.
  • Demonstrate improvement in competence, performance or patient outcomes.
  • Apply strategies to maintain wellness and prevent burnout.

Accreditation and Designation Statements

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this Other activity (Live in-person, Internet Live and Internet Enduring) for a maximum of 74.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAP designates this Other activity (Internet Live and Internet Enduring) for a maximum of 43.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.*

This activity is acceptable for a maximum of 74.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

PAs may claim a maximum of 74.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

This program is accredited for 74.00 NAPNAP CE contact hours of which 16.75 contain pharmacology (Rx) content, (2.00 related to psychopharmacology) (5.50 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines.

This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation. This program is accredited for 74.00 contact hours, including 16.75 pharmacology (Rx) contact hours. Criteria for successful completion includes participating in sessions at the conference and completing the program evaluation.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 20.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

If you do not successfully complete all components of the activity and evaluation assessment ABP MOC Part 2 Points will not be awarded.

Please note: your completion data will be shared with the ABP through the ACCME PARS system within 30 days of successful completion. This will include the name of the activity and provider; participant name; participant’s ABP ID number; participant’s DOB; date of completion of the activity; the PARS activity identifier; ABP MOC Part 2 credit statement and number of MOC points awarded.  If any questions or concerns, please contact the AAP at nce@aap.org.

Special sessions and events that are not designated for AMA PRA Category 1 Credits™ are identified throughout the conference platform.

Sessions that include pharmacology (Rx) credit will be identified throughout the conference platform.

*Virtual-only participants will have access to up to 43.00 AMA PRA Category 1 Credits.

*One-Day participants will have access to claim AMA PRA Category 1 Credits™ based on the maximum amount below.

 

Disclosures & Faculty

DISCLOSURE OF FINANCIAL RELATIONSHIPS AND MITIGATION OF CONFLICTS OF INTEREST FOR AAP CME ACTIVITIES

The AAP recognizes that there are a variety of financial relationships between individuals and ineligible companies that require review to identify possible conflicts of interest in a CME activity. The “AAP Policy on Disclosure of Financial Relationships and Mitigation of Conflicts of Interest for AAP CME Activities” is designed to ensure quality, objective, balanced, and scientifically rigorous AAP CME activities by identifying and resolving all potential conflicts of interest prior to the confirmation of service of those in a position to influence and/or control CME content. The AAP has taken steps to mitigate any potential conflicts of interest. The purpose of this policy is to ensure all potential conflicts of interest are identified and mechanisms to mitigate them prior to the CME activity are implemented in ways that are consistent with the public good. the AAP is committed to providing learners with commercially unbiased CME activities.

All AAP CME activities will strictly adhere to the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support: Standards to Ensure the Independence of CME Activities. In accordance with these Standards, the following decisions will be made free of the control of an ineligible company: identification of CME needs, determination of educational objectives, selection and presentation of content, selection of all persons and organizations that will be in a position to control the content, selection of educational methods, and evaluation of the CME activity.

Disclosure of Financial Relationships

All individuals in a position to influence and/or control the content of AAP CME activities are required to disclose to the AAP and subsequently to learners that the individual either has no financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. An ineligible company is defined as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.  Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content.  All of the relevant financial relationships listed for these individuals have been mitigated.  This activity may discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical. 

All 2024 National Conference conflict of interest disclosures can be found below. Please note, there may be discrepancies in the provided list of disclosures compared to faculty/participant verbal disclosures in the session due to changes or relevance. All of the relevant financial relationships listed for these individuals have been mitigated. 

CLICK HERE FOR CONFLICT OF INTEREST DISCLOSURES as of 06/01/2024

 

This activity may discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical. Individual faculty/participants will note when “off-label” use is being presented.

Method of Participation and Minimum Performance Level

Individuals will participate in this activity in-person, onsite in Orlando, FL and/or via an internet connection. Participants must either attend in-person or online to view at least one live or enduring session. All attendees must login to the conference platform at least once prior to January 31, 2025 to be eligible to claim credit and attest to their participation. Following attestation of participation, participants will be able to claim their credit and print a certificate. Because credit can only be claimed once, please do not claim credit until you have completed all live and/or enduring sessions in which you plan to participate.

Individuals can participate in the activity via live in-person, live internet and/or enduring sessions at a time they choose until January 31, 2025.  Scheduled livestream sessions will be recorded and made available after the conference to all attendees by October 3, 2024. All sessions must be completed by January 31, 2025. Slides and session recordings will be posted in the Conference Platform through January 31, 2025.

NAME OF MEDIUM OR COMBINATION OF MEDIA USED FOR VIRTUAL ATTENDANCE

Livestream and enduring sessions will be accessed via a computer or mobile device with audio and internet connection.

HARDWARE & SOFTWARE REQUIREMENTS FOR VIRTUAL ATTENDANCE

In order to have the best experience with our streaming media services, it is recommended that you test the ability to receive streaming media before the day of this event on the computer or mobile device you will be using to participate in the activity.

SYSTEM REQUIREMENTS FOR VIRTUAL ATTENDANCE

The system requirements for viewing a streaming media event are:

Windows

  • Windows 10 or Windows 8
  • Display resolution of 800×600 pixels or greater
  • Firefox 71.0 or later, or Google Chrome 84.0 For Firefox and Chrome, Silverlight 0 or later
  • Broadband Internet connection
  • No network blocks or filters that disable streaming media

MAC

  • Mac OS X 10.4.8 or later
  • Safari 13.0.1 or later (or Firefox 71.0 or later) Silverlight 0
  • Broadband Internet connection
  • No network blocks or filters that disable streaming media

 

Product-Specific Advertising/Links to Product Websites

No product-specific advertising of any type appears in this educational activity/content. No links to product websites appear in this educational activity/content.

Privacy and Confidentiality Statement

At the American Academy of Pediatrics (AAP), we take the issue of privacy very seriously. We do not sell, distribute, barter, or transfer personally identifiable information obtained from a user to a third party without your consent. Any information collected on the Web site is only used for the purpose stated.  The AAP list is only for important communications, and your e-mail address will not be sold or provided to third parties.  You will not receive advertising or promotional materials on this list.

The AAP may use “cookie” technology to obtain non-personal information from its online visitors.  We do not extract personal information in this process nor do we provide this information to third parties.  We also do not contact you based on the information in your cookie file.

The AAP has taken steps to make all information received from our online visitors as secure as possible against unauthorized access and use.  All information is protected by our security measures, which are periodically reviewed.

Need More Help?

If you have any questions or need assistance, please contact nce@aap.org.